Xiao-Fan Huang Selected Research

butylidenephthalide

1/2021	Positively Charged Nanoparticle Delivery of n-Butylidenephthalide Enhances Antitumor Effect in Hepatocellular Carcinoma.
1/2021	Enhancement of cytotoxicity and induction of apoptosis by cationic nano-liposome formulation of n-butylidenephthalide in breast cancer cells.
5/2020	Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells.
1/2020	Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma.
12/2018	Antitumor Effect of n-Butylidenephthalide Encapsulated on B16/F10 Melanoma Cells In Vitro with a Polycationic Liposome Containing PEI and Polyethylene Glycol Complex.
1/2015	Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Fan Huang Research Topics

Disease

17	Neoplasms (Cancer) 06/2021 - 01/2013
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2020
4	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2013
3	Melanoma (Melanoma, Malignant) 01/2021 - 12/2018
2	Body Weight (Weight, Body) 01/2021 - 10/2020
2	Mouth Neoplasms (Oral Cancer) 06/2020 - 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2021
1	Diabetes Mellitus 09/2021
1	Renal Insufficiency (Renal Failure) 09/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Leukemia 11/2020
1	Colonic Neoplasms (Colon Cancer) 05/2020
1	Colorectal Neoplasms (Colorectal Cancer) 05/2020
1	Neuroblastoma 01/2020
1	Anemia 12/2018
1	Glomerulonephritis 01/2013

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
6	butylidenephthalideIBA 01/2021 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
3	Antineoplastic Agents (Antineoplastics)IBA 06/2021 - 06/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 10/2020
2	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 01/2021 - 04/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2020
2	Liposomes (Liposome)IBA 01/2021 - 12/2018
2	cedrolIBA 12/2020 - 10/2020
2	PolyethyleneimineIBA 05/2020 - 12/2018
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2020 - 12/2018
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Apoptosis Regulatory ProteinsIBA 01/2021
1	Cell Cycle ProteinsIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	Volatile Oils (Essential Oils)IBA 11/2020
1	Caspase 3 (Caspase-3)IBA 10/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2020
1	CaspasesIBA 06/2020
1	Drug CarriersIBA 05/2020
1	Cytotoxins (Cytolysins)IBA 05/2020
1	Immunoglobulin G (IgG)IBA 04/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Therapeutic UsesIBA 01/2020
1	Methanol (Carbinol)IBA 01/2013

Therapy/Procedure

8	Therapeutics 06/2021 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2013
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2013
2	Aftercare (After-Treatment) 01/2021 - 12/2018
1	Blood Transfusion (Blood Transfusions) 09/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 09/2021
1	Intravenous Administration 01/2015